Results 251 to 260 of about 3,011,044 (294)

Pharmacotherapy in congestive heart failure: Hyperkalemia in congestive heart failure.

Congestive heart failure (Greenwich, Conn.)
Hyperkalemia is not an uncommon occurrence in the congestive heart failure patient, particularly when renal failure coexists. Hyperkalemia in CHF is typically medication-related. Its occurrence is inevitably linked to the simultaneous ingestion of angiotensin-converting enzyme inhibitors and beta-blockers, and more recently, aldosterone receptor ...
T WB, Gehr, D A, Sica
openaire   +2 more sources

CONGESTIVE HEART FAILURE IN CHILDREN

Pediatric Clinics of North America, 1999
Although revitalizing dead or severely injured myocardial cells is still beyond the reach of modern treatment, the ability to change the loading conditions and the contractile state of the heart has enabled practitioners to reverse deleterious compensatory mechanisms in patients with CHF.
openaire   +2 more sources

Glucagon in Congestive Heart Failure

Chest, 1971
Nineteen patients with congestive heart failure were given a continuous infusion of glucagon 3 to 5 mg/hour. Those with acute processes improved, while only 1 of 12 with chronic CHF benefited. Urine output increased 495 ml/24 hours, BUN rose 4.9 mg percent, serum glucose increased 22.1 mg percent, and serum potassium decreased 0.35 mEq/liter.
R J, Kones, J H, Phillips
openaire   +2 more sources

Pathophysiology of congestive heart failure

The American Journal of Cardiology, 1985
Congestive heart failure is a syndrome common in the United States, especially in elderly patients. The most common etiology is coronary artery disease. A number of general factors contribute to the heart failure syndrome, including loss of muscle, decreased myocardial contractility, pressure or volume overload, or restricted filling.
openaire   +4 more sources

Congestive Heart Failure in the Cat

Journal of the American Veterinary Medical Association, 1970
SUMMARY Congestive heart failure was diagnosed by means of clinical, radiographic, and necropsy findings in 129 of 45,004 cats examined from January, 1962, to June, 1969, in a hospital clinic in New York City. Twenty-two cats had congenital anomalies of the heart, and 107 cats had acquired cardiac lesions.
S K, Liu, R J, Tashjian, A K, Patnaik
openaire   +2 more sources

The kidney in congestive heart failure

European Heart Journal, 1991
Congestive heart failure (CHF) is characterized by activation of (i) vasopressor and antinatriuretic influences (ii) and by counter-activation of vasodilator natriuretic systems. The former comprise the sympathoadrenal, renin-angiotensin-aldosterone and arginine vasopressin systems, and possibly endothelin and withdrawal of endothelium dependent ...
E, Ritz, D, Fliser
openaire   +2 more sources

SPLENOMEGALY IN CONGESTIVE HEART FAILURE

Annals of Internal Medicine, 1947
Excerpt During the past few years, we have noted several instances of palpable spleen in patients with chronic cardiac decompensation; no other reason for splenic enlargement was found in these cas...
openaire   +2 more sources

Viability and Congestive Heart Failure

Heart Failure Clinics
Management of ischemic cardiomyopathy is challenging, especially when treatment benefits do not clearly exceed the estimated risk of procedures. Myocardial viability assessment provides additional data in this setting to anticipate potential functional recovery and possibly prognostic improvement following revascularization.
Mehmet, Onur Omaygenc, Lisa Marie, Mielniczuk   +1 more
openaire   +2 more sources

Congestive Heart Failure

American Journal of Respiratory and Critical Care Medicine, 2002
Athena, Poppas, Sharon, Rounds
openaire   +2 more sources

‘Congestive Heart Failure’ and Bradycardia

Hospital Practice, 1994
(1994). ‘Congestive Heart Failure’ and Bradycardia. Hospital Practice: Vol. 29, No. 1, pp. 111-114.
openaire   +2 more sources